SMO and neoplasm: When tested in vivo, dactolisib could reduce tumor volume, vascularity and metastasis and improve animal survival, especially when combined with other drugs, such as topotecan, carboplatin, vincristine or the SMO inhibitor LDE225 [773,781,782,783].